Oragenics, Inc

(NYSE MKT:OGEN)

Latest On Oragenics, Inc (OGEN):

Date/Time Type Description Signal Details
2023-03-08 13:23 ESTNewsOragenics names industry veteran for CFO roleN/A
2023-03-01 14:39 ESTNewsOragenics jumps 14% on licensing deal for intranasal covid vaccine candidateN/A
2023-02-03 10:55 ESTNewsOragenics regains compliance with NYSE's continued listing standardsN/A
2022-12-24 03:57 ESTNewsOragenics announces 1-for-60 reverse share splitN/A
2022-12-22 19:10 ESTNewsOragenics gains after final toxicology data for intranasal COVID vaccineN/A
2022-12-21 08:47 ESTNewsOragenics gets non-compliance notice from NYSE AmericanN/A
2022-08-24 07:57 ESTNewsOragenics announces early toxicology data for intranasal COVID-19 vaccineN/A
2022-06-23 17:38 ESTNewsOragenics names former GSK exec Kimberly Murphy as CEON/A
2022-06-14 20:33 ESTNewsOragenics announces peer-reviewed positive data publication for nasal COVID shot candidateN/A
2022-04-06 19:20 ESTNewsOragenics extends collaboration deal to develop vaccines against future COVID-19 variantsN/A
2022-03-26 07:08 ESTNewsOragenics drops after flagging audit concernsN/A
2022-03-23 09:05 ESTNewsOragenics begins toxicology study in animals to test intranasal COVID-19 vaccine candidateN/A
2022-01-04 16:32 ESTNewsOragenics shares spike 27% after Director buys 1M sharesN/A
2021-12-02 02:47 ESTNewsOragenics shares results for COVID-19 vaccine candidate from second pre-clinical studyN/A
2021-09-22 02:33 ESTNewsOragenics initiates COVID-19 vaccine hamster challenge studyN/A
2021-08-30 16:59 ESTNewsOragenics says SARS-CoV-2 spike protein produces neutralizing antibodies in miceN/A
2021-07-27 14:17 ESTNewsOragenics shares soar on licensing agreement to develop COVID-19 vaccinesN/A
2021-03-09 21:20 ESTNewsOragenics inks material transfer agreement for COVID-19 vaccine adjuvantsN/A
2021-03-03 20:23 ESTFinancialsCompany financials have been released.Neutral
2021-03-03 08:25 ESTEarnings EstimateAn EPS average of -$0.20 is estimated for the 2022 year.Sell
2021-02-12 22:37 ESTNewsOragenics secures $20M capital raiseN/A
2021-02-10 16:13 ESTNewsTLRY, GLUU, ABEO and TYME among premarket gainersN/A
2021-02-10 08:11 ESTAnalyst RatingThe Analyst Target Price has increased from $2.75 to $3.Buy
2021-01-07 15:06 ESTNewsOragenics enters into material transfer agreement for COVID-19 vaccine adjuvantN/A
2020-12-24 09:52 ESTNewsOragenics announces $6.5M direct offeringN/A
2020-12-04 04:22 ESTAnalyst RatingThe Analyst Target Price has increased from $2.5 to $2.75.Buy
2020-11-26 21:04 ESTFinancialsCompany financials have been released.Neutral
2020-11-21 01:59 ESTNewsOragenics shares drop 28% after pricing $5.25M stock offeringN/A
2020-11-20 00:05 ESTNewsOragenics launches equity offeringN/A
2020-11-17 20:44 ESTFinancialsCompany financials have been released.Neutral
2020-11-08 00:25 ESTFinancialsCompany financials have been released.Neutral
2020-11-07 16:42 ESTFinancialsCompany financials have been released.Neutral
2020-10-06 19:04 ESTNewsFDA backs Oragenics' Pre-IND development program for SARS-CoV-2 vaccineN/A
2020-09-29 06:00 ESTNewsOragenics comes up empty in pursuit of BARDA funding for COVID-19 vaccineN/A
2020-09-26 13:37 ESTFinancialsCompany financials have been released.Neutral
2020-09-17 05:43 ESTFinancialsCompany financials have been released.Neutral
2020-08-21 00:44 ESTNewsOragenics inks deal with Avid Bio for advancement of COVID-19 vaccineN/A
2020-08-16 13:22 ESTFinancialsCompany financials have been released.Neutral
2020-08-14 09:41 ESTFinancialsCompany financials have been released.Neutral
2020-08-06 13:26 ESTFinancialsCompany financials have been released.Neutral
2020-07-31 01:54 ESTFinancialsCompany financials have been released.Neutral
2020-07-30 17:23 ESTFinancialsCompany financials have been released.Neutral
2020-07-30 05:23 ESTFinancialsCompany financials have been released.Neutral
2020-07-27 13:19 ESTFinancialsCompany financials have been released.Neutral
2020-07-23 17:58 ESTFinancialsCompany financials have been released.Neutral
2020-07-23 02:42 ESTNewsOragenics rallies on encouraging data supporting potential COVID-19 vaccineN/A
2020-07-10 19:52 ESTNewsOragenics +13% on advancement of COVID-19 vaccine programN/A
2020-07-09 09:34 ESTFinancialsCompany financials have been released.Neutral
2020-07-01 17:21 ESTFinancialsCompany financials have been released.Neutral
2020-06-26 09:34 ESTFinancialsCompany financials have been released.Neutral

About Oragenics, Inc (OGEN):

Oragenics, Inc. develops antibiotics for infectious diseases in the United States. Its lead product candidate under development is OG716, an antibiotic for the treatment of Clostridium difficile. The company also engages in the development and commercialization of Terra CoV-2, a vaccine product candidate that provides immunity from the novel severe acute respiratory syndrome coronavirus. Its product candidates also comprise LPT3-04, a weight loss candidate; and SMaRT Replacement Therapy, a topical treatment to prevent dental carries. The company has a license agreement with Noachis Terra Inc. for licensing of certain specified patent rights and biological materials relating to the use of pre-fusion coronavirus spike proteins; and a collaboration agreement with Precigen, Inc. and ILH Holdings, Inc. for the development and production of lantibiotics, a peptide antibiotic that are naturally produced in gram-positive bacteria. The company was formerly known as Oragen, Inc. Oragenics, Inc. was incorporated in 1996 and is headquartered in Tampa, Florida.

OGEN Quotes by TradingView

See Advanced Chart

General

  • Name Oragenics, Inc
  • Symbol OGEN
  • Type Common Stock
  • Exchange NYSE MKT
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 7
  • Last Split Factor1:10
  • Last Split Date2018-01-22
  • Fiscal Year EndDecember
  • IPO Date2004-02-25
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.oragenics.com
View More

Valuation

  • Price/Book (Most Recent Quarter) 11.91
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$0.20
  • Next Year EPS Estimate -$0.20
  • Return on Assets -87%
  • Return on Equity -155%
  • Earnings Per Share -$0.51
  • Revenue Per Share $0
  • Quarterly Earnings Growth 0%
View More

Highlights

  • Market Capitalization 110.74 million
  • EBITDA -13843793
  • Analyst Target Price $3
  • Book Value Per Share $0.11
View More

Share Statistics

  • Shares Outstanding 109.65 million
  • Shares Float 108.01 million
  • % Held by Insiders 695%
  • % Held by Institutions 7.43%
  • Shares Short 2.54 million
  • Shares Short Prior Month 3.35 million
  • Short Ratio 0.14
  • Short % of Float 2%
  • Short % of Shares Outstanding 2%
View More

Technicals

  • Beta 0.27
  • 52 Week High $2.09
  • 52 Week Low $0.36
  • 50 Day Moving Average 1.1
  • 200 Day Moving Average 0.72
View More

Dividends

  • Dividend Date 2018-01-22
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Oragenics, Inc (OGEN) Dividend Calendar:

OGEN's last dividend payment was made to shareholders on January 22, 2018.

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Oragenics, Inc (OGEN) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-01$N/A-$0.05-$0.0616.67%
2020-09-302020-11-10$N/A-$0.08-$0.07-14.29%
2020-06-302020-08-14$N/A-$0.24-$0.09-166.67%
2020-03-312020-05-15$N/A-$0.11-$0.08-37.5%
2019-12-312020-03-04$N/A-$0.08-$0.1017.27%
2019-09-302019-11-14$N/A-$0.08-$0.0911.11%
2019-06-302019-08-14$N/A-$0.10-$0.07-49.93%
2019-03-312019-05-13$N/A-$0.11-$0.09-26.87%
2018-12-312019-03-29$N/A-$0.09-$0.1010%
2018-09-302018-11-13$N/A-$0.35-$0.21-66.67%
2018-06-302018-08-13$N/A-$0.38-$0.4515.56%
2018-03-312018-05-15$N/A-$0.42
2017-12-312018-02-16$N/A-$0.30
2017-09-302017-10-31$N/A-$0.42
2017-06-302017-08-14$N/A-$0.25
2017-03-312017-05-15$N/A-$0.40
2016-12-312017-02-27$N/A-$0.54
2016-09-302016-11-14$262258-$0.40-$0.400%
2016-06-302016-08-15$-524516-$0.08
2016-03-312016-05-16$262258-$0.52
2015-12-312016-03-30$240234-$0.60
2015-09-302015-11-06$329795-$0.51
2015-06-302015-08-07$242038-$1.74
2015-03-312015-05-08$363774-$0.36
2014-12-312015-02-27$221000-$0.34
2014-09-302014-11-03$201000-$0.28
2014-06-302014-08-07$303000-$0.50-$1.0050%
2014-03-312014-05-09$215000-$0.50-$0.9044.44%
2013-12-312014-03-03$435000-$0.90
2013-09-302013-10-25$253000-$3.39
2013-06-302013-08-12$168000-$0.75
2013-03-312013-05-15$176000-$0.60-$0.7014.29%
2012-12-312013-03-26$431000-$1.10-$0.70-57.14%
2012-09-302012-11-16$264000-$1.07
2012-06-302012-08-10$256000-$5.18
2012-03-312012-05-11$381000-$2.51
2011-12-312012-03-20$396000-$3.39
2011-09-302011-11-11$350000-$3.18
2011-06-302011-08-12$348000-$4.18
2011-03-312011-05-13$350000-$2.75
2010-12-312011-03-22$298000-$3.94
2010-09-302010-11-12$365000-$3.36
2010-06-302010-08-13$305000-$3.72
2010-03-312010-05-14$341000-$3.24
2009-12-312010-03-16$275000-$2.00
2009-09-302009-11-13$200000-$3.18
2009-06-302009-08-14$42000-$4.47
2009-03-312009-05-20$124000-$11.29
2008-12-312009-03-17$9000-$17.09
2008-09-302008-12-03$100000-$5.94
2008-06-302008-08-14$-125000-$6.50
2008-03-312008-05-07$125000-$5.31
2007-09-302007-11-28$46000-$3.75
2007-06-302007-08-13$27000-$6.00-$8.0025%
2007-03-312007-05-11$33000-$6.00-$6.000%
2006-12-312007-03-23$N/A-$6.00-$6.000%
2006-09-302006-11-13$66000-$6.00-$4.00-50%
2006-06-302006-08-11$N/A-$8.00-$8.000%
2006-03-312006-05-31$N/A-$9.23
2005-12-312006-03-01$N/A-$10.00
2005-09-302005-11-30$N/A-$9.88
2005-06-302005-08-11$N/A-$11.82
2005-03-312005-06-01$N/A-$11.87
2004-12-312005-03-02$33000-$18.00
2004-09-302004-12-01$119000-$8.57
2004-06-302004-08-11$44000-$9.33
2004-03-312004-03-31$N/A-$8.01
2003-12-312003-12-31$N/A-$10.00
2003-09-302003-09-30$N/A-$6.63

Oragenics, Inc (OGEN) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Oragenics, Inc (OGEN) Chart:

Oragenics, Inc (OGEN) News:

Below you will find a list of latest news for Oragenics, Inc (OGEN) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Oragenics, Inc (OGEN) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent

Latest OGEN Trades:

Date Shares Price
Jun 13, 2022 6:28 PM EST1$0.3112
Jun 13, 2022 7:12 PM EST5$0.3051

Oragenics, Inc (OGEN) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-30424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1174940/000149315220012304/0001493152-20-012304-index.htm
2020-01-06UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1174940/000000000020000100/0000000000-20-000100-index.htm
2020-06-15UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1174940/000000000020005279/0000000000-20-005279-index.htm
2018-06-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1174940/000089924318018136/0000899243-18-018136-index.htm
2018-06-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1174940/000089924318018137/0000899243-18-018137-index.htm
2018-06-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1174940/000089924318018140/0000899243-18-018140-index.htm
2018-06-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1174940/000089924318018147/0000899243-18-018147-index.htm
2018-06-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1174940/000089924318018151/0000899243-18-018151-index.htm
2018-06-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1174940/000089924318018154/0000899243-18-018154-index.htm
2018-07-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1174940/000089924318019954/0000899243-18-019954-index.htm
2018-07-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1174940/000089924318019955/0000899243-18-019955-index.htm
2018-09-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1174940/000089924318024657/0000899243-18-024657-index.htm
2018-10-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1174940/000089924318025656/0000899243-18-025656-index.htm
2018-10-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1174940/000089924318025657/0000899243-18-025657-index.htm
2018-10-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1174940/000089924318025658/0000899243-18-025658-index.htm
2018-10-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1174940/000089924318025659/0000899243-18-025659-index.htm
2018-10-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1174940/000089924318025660/0000899243-18-025660-index.htm
2018-10-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1174940/000089924318025663/0000899243-18-025663-index.htm
2019-03-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1174940/000089924319009014/0000899243-19-009014-index.htm
2019-03-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1174940/000089924319009015/0000899243-19-009015-index.htm
2019-06-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1174940/000089924319017956/0000899243-19-017956-index.htm
2019-06-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1174940/000089924319017957/0000899243-19-017957-index.htm
2019-06-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1174940/000089924319017958/0000899243-19-017958-index.htm
2019-06-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1174940/000089924319017959/0000899243-19-017959-index.htm
2019-08-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1174940/000089924319021485/0000899243-19-021485-index.htm
2019-08-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1174940/000089924319021488/0000899243-19-021488-index.htm
2019-08-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1174940/000089924319021489/0000899243-19-021489-index.htm
2019-08-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1174940/000089924319021491/0000899243-19-021491-index.htm
2018-07-18SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1174940/000090266418002883/0000902664-18-002883-index.htm
2019-01-17SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1174940/000090266419000277/0000902664-19-000277-index.htm
2019-03-29SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1174940/000110465919018578/0001104659-19-018578-index.htm
2020-02-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1174940/000110465920013416/0001104659-20-013416-index.htm
2020-03-02SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1174940/000114036120004553/0001140361-20-004553-index.htm
2020-10-08SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1174940/000114036120022712/0001140361-20-022712-index.htm
2018-05-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1174940/000119312518175281/0001193125-18-175281-index.htm
2018-05-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1174940/000119312518177717/0001193125-18-177717-index.htm
2018-06-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1174940/000119312518189554/0001193125-18-189554-index.htm
2018-06-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1174940/000119312518204110/0001193125-18-204110-index.htm
2018-06-26S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1174940/000119312518204169/0001193125-18-204169-index.htm
2018-07-05S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1174940/000119312518213187/0001193125-18-213187-index.htm
2018-07-05FWPFiling under Securities Act Rules 163/433 of free writing prospectuseshttps://www.sec.gov/Archives/edgar/data/1174940/000119312518213191/0001193125-18-213191-index.htm
2018-07-09S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1174940/000119312518213992/0001193125-18-213992-index.htm
2018-07-11CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1174940/000119312518215934/0001193125-18-215934-index.htm
2018-07-11CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1174940/000119312518215939/0001193125-18-215939-index.htm
2018-07-11S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1174940/000119312518216127/0001193125-18-216127-index.htm
2018-07-12S-1MEFRegistration adding securities to prior Form S-1 registration [Rule 462(b)]https://www.sec.gov/Archives/edgar/data/1174940/000119312518216974/0001193125-18-216974-index.htm
2018-07-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1174940/000119312518217414/0001193125-18-217414-index.htm
2018-07-13424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1174940/000119312518217823/0001193125-18-217823-index.htm
2018-07-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1174940/000119312518219721/0001193125-18-219721-index.htm
2018-08-1310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1174940/000119312518247326/0001193125-18-247326-index.htm
2018-08-13SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1174940/000119312518247395/0001193125-18-247395-index.htm
2018-08-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1174940/000119312518249271/0001193125-18-249271-index.htm
2018-09-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1174940/000119312518282624/0001193125-18-282624-index.htm
2018-10-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1174940/000119312518289512/0001193125-18-289512-index.htm
2018-10-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1174940/000119312518294793/0001193125-18-294793-index.htm
2018-10-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1174940/000119312518300677/0001193125-18-300677-index.htm
2018-12-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1174940/000119312518341244/0001193125-18-341244-index.htm
2018-12-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1174940/000119312518356398/0001193125-18-356398-index.htm
2019-02-14SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1174940/000119312519041051/0001193125-19-041051-index.htm
2019-02-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1174940/000119312519048432/0001193125-19-048432-index.htm
2019-03-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1174940/000119312519076806/0001193125-19-076806-index.htm
2019-03-20424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1174940/000119312519080977/0001193125-19-080977-index.htm
2019-03-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1174940/000119312519080981/0001193125-19-080981-index.htm
2019-03-20S-3MEFRegistration adding securities to prior Form S-3 registration [Rule 462(b)]https://www.sec.gov/Archives/edgar/data/1174940/000119312519081235/0001193125-19-081235-index.htm
2019-03-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1174940/000119312519081612/0001193125-19-081612-index.htm
2019-03-22424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1174940/000119312519082478/0001193125-19-082478-index.htm
2019-03-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1174940/000119312519085324/0001193125-19-085324-index.htm
2019-03-29SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1174940/000119312519092647/0001193125-19-092647-index.htm
2019-06-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1174940/000119312519178907/0001193125-19-178907-index.htm
2019-06-24S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1174940/000119312519180048/0001193125-19-180048-index.htm
2019-09-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1174940/000119312519240113/0001193125-19-240113-index.htm
2019-09-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1174940/000119312519251554/0001193125-19-251554-index.htm
2019-09-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1174940/000119312519254190/0001193125-19-254190-index.htm
2019-09-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1174940/000119312519258123/0001193125-19-258123-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1174940/000119312520038413/0001193125-20-038413-index.htm
2019-04-01SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1174940/000121390019005305/0001213900-19-005305-index.htm
2020-02-11SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1174940/000121390020003198/0001213900-20-003198-index.htm
2020-05-153Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1174940/000121390020012646/0001213900-20-012646-index.htm
2020-05-15SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1174940/000121390020012649/0001213900-20-012649-index.htm
2018-07-23SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1174940/000138713118003280/0001387131-18-003280-index.htm
2019-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1174940/000138713119001107/0001387131-19-001107-index.htm
2019-10-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1174940/000149315219015794/0001493152-19-015794-index.htm
2019-11-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1174940/000149315219017458/0001493152-19-017458-index.htm
2019-12-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1174940/000149315219018612/0001493152-19-018612-index.htm
2019-12-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1174940/000149315219018709/0001493152-19-018709-index.htm
2019-12-31S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1174940/000149315219019926/0001493152-19-019926-index.htm
2019-12-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1174940/000149315219019927/0001493152-19-019927-index.htm
2020-01-09CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1174940/000149315220000401/0001493152-20-000401-index.htm
2020-01-24SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1174940/000149315220001042/0001493152-20-001042-index.htm
2020-02-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1174940/000149315220001765/0001493152-20-001765-index.htm
2020-02-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1174940/000149315220001768/0001493152-20-001768-index.htm
2020-02-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1174940/000149315220001774/0001493152-20-001774-index.htm
2020-02-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1174940/000149315220001781/0001493152-20-001781-index.htm
2020-02-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1174940/000149315220001783/0001493152-20-001783-index.htm
2020-02-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1174940/000149315220001786/0001493152-20-001786-index.htm
2020-02-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1174940/000149315220001790/0001493152-20-001790-index.htm
2020-03-0410-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1174940/000149315220003343/0001493152-20-003343-index.htm
2020-03-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1174940/000149315220003925/0001493152-20-003925-index.htm
2020-04-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1174940/000149315220006424/0001493152-20-006424-index.htm
2020-05-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1174940/000149315220007585/0001493152-20-007585-index.htm
2020-05-043Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1174940/000149315220007669/0001493152-20-007669-index.htm
2020-05-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1174940/000149315220007670/0001493152-20-007670-index.htm
2020-05-06DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1174940/000149315220007826/0001493152-20-007826-index.htm
2020-05-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1174940/000149315220008008/0001493152-20-008008-index.htm
2020-05-1510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1174940/000149315220009088/0001493152-20-009088-index.htm
2020-05-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1174940/000149315220009137/0001493152-20-009137-index.htm
2020-05-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1174940/000149315220009138/0001493152-20-009138-index.htm
2020-05-298-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1174940/000149315220010137/0001493152-20-010137-index.htm
2020-05-29S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1174940/000149315220010143/0001493152-20-010143-index.htm
2020-06-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1174940/000149315220010649/0001493152-20-010649-index.htm
2020-06-19PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/1174940/000149315220011497/0001493152-20-011497-index.htm
2020-06-19CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1174940/000149315220011513/0001493152-20-011513-index.htm
2020-06-26CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1174940/000149315220011915/0001493152-20-011915-index.htm
2020-06-30424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1174940/000149315220012304/0001493152-20-012304-index.htm
2020-07-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1174940/000149315220013051/0001493152-20-013051-index.htm
2020-07-13DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1174940/000149315220013162/0001493152-20-013162-index.htm
2020-07-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1174940/000149315220013769/0001493152-20-013769-index.htm
2020-07-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1174940/000149315220014009/0001493152-20-014009-index.htm
2020-08-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1174940/000149315220015841/0001493152-20-015841-index.htm
2020-08-148-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1174940/000149315220015854/0001493152-20-015854-index.htm
2020-08-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1174940/000149315220016154/0001493152-20-016154-index.htm
2020-08-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1174940/000149315220016384/0001493152-20-016384-index.htm
2020-08-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1174940/000149315220016611/0001493152-20-016611-index.htm
2020-09-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1174940/000149315220017603/0001493152-20-017603-index.htm
2020-09-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1174940/000149315220018404/0001493152-20-018404-index.htm
2020-10-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1174940/000149315220018975/0001493152-20-018975-index.htm
2019-01-04SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1174940/000153561019000029/0001535610-19-000029-index.htm
2018-11-1310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1174940/000156459018029292/0001564590-18-029292-index.htm
2019-03-2910-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1174940/000156459019010173/0001564590-19-010173-index.htm
2019-04-2910-K/AAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1174940/000156459019013787/0001564590-19-013787-index.htm
2019-05-1310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1174940/000156459019018818/0001564590-19-018818-index.htm
2019-05-16DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1174940/000156459019019620/0001564590-19-019620-index.htm
2019-08-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1174940/000156459019032130/0001564590-19-032130-index.htm
2018-07-12EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1174940/999999999518001773/9999999995-18-001773-index.htm
2020-01-13EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1174940/999999999520000082/9999999995-20-000082-index.htm
2020-06-30EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1174940/999999999520001679/9999999995-20-001679-index.htm

Oragenics, Inc (OGEN) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Oragenics, Inc (OGEN). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 695%
Institutional Ownership: 743%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2019-12-30ROBERT C KOSKIDirectorSell100,000.000.5352,610.001,086,483.00https://www.sec.gov/Archives/edgar/data/1174940/000149315219019927/0001493152-19-019927-index.htm
2018-06-22FAMILY LP KOSKIDirectorBuy4,000.00108,789.00https://www.sec.gov/Archives/edgar/data/1174940/000089924318018147/0000899243-18-018147-index.htm
2019-12-27ROBERT C KOSKIDirectorSell100,000.000.5251,670.001,186,483.00https://www.sec.gov/Archives/edgar/data/1174940/000149315219019927/0001493152-19-019927-index.htm
2018-06-22Fred TellingDirectorBuy4,000.00139,538.00https://www.sec.gov/Archives/edgar/data/1174940/000089924318018136/0000899243-18-018136-index.htm
2018-09-14FAMILY LP KOSKI10% Share HolderBuy38,860.000.4216,321.20147,649.00https://www.sec.gov/Archives/edgar/data/1174940/000089924318024657/0000899243-18-024657-index.htm
2018-09-14FAMILY LP KOSKI10% Share HolderBuy2,000.000.42830.00149,649.00https://www.sec.gov/Archives/edgar/data/1174940/000089924318024657/0000899243-18-024657-index.htm
2018-09-14FAMILY LP KOSKI10% Share HolderBuy100.000.4141.10149,749.00https://www.sec.gov/Archives/edgar/data/1174940/000089924318024657/0000899243-18-024657-index.htm
2018-09-14FAMILY LP KOSKI10% Share HolderBuy6,090.000.412,525.52155,839.00https://www.sec.gov/Archives/edgar/data/1174940/000089924318024657/0000899243-18-024657-index.htm
2018-06-22ALAN W DUNTONDirectorBuy4,000.0021,261.00https://www.sec.gov/Archives/edgar/data/1174940/000089924318018151/0000899243-18-018151-index.htm
2018-07-17Fred TellingDirectorBuy100,000.00239,538.00https://www.sec.gov/Archives/edgar/data/1174940/000089924318019954/0000899243-18-019954-index.htm
2018-09-17FAMILY LP KOSKI10% Share HolderBuy100,000.000.4242,000.00255,839.00https://www.sec.gov/Archives/edgar/data/1174940/000089924318024657/0000899243-18-024657-index.htm
2018-09-18FAMILY LP KOSKI10% Share HolderBuy22,000.000.419,009.00277,839.00https://www.sec.gov/Archives/edgar/data/1174940/000089924318024657/0000899243-18-024657-index.htm
2018-06-22CHARLES L POPEDirectorBuy4,000.0028,108.00https://www.sec.gov/Archives/edgar/data/1174940/000089924318018154/0000899243-18-018154-index.htm
2019-03-25Fred TellingDirectorBuy100,000.00339,538.00https://www.sec.gov/Archives/edgar/data/1174940/000089924319009014/0000899243-19-009014-index.htm
2018-07-17ALAN W DUNTONDirectorBuy20,000.0041,261.00https://www.sec.gov/Archives/edgar/data/1174940/000089924318019955/0000899243-18-019955-index.htm
2019-03-25Alan JoslynOfficerBuy66,667.0066,667.00https://www.sec.gov/Archives/edgar/data/1174940/000089924319009015/0000899243-19-009015-index.htm